⚖️ Files federal trademark or copyright suits

Novartis AG Corporation

Trademark enforcement profile · on record 1998–2026

Novartis AG Corporation has filed federal trademark or copyright enforcement actions. On record (1998–2026): 5 federal trademark or copyright lawsuits; 143 oppositions and cancellation petitions at the USPTO Trademark Trial and Appeal Board (prevailed in 66% of merits decisions).

Data summary based on public records (USPTO TTAB proceedings and PACER/CourtListener federal court dockets). Figures reflect filings on record, not a characterization of the merits or good faith of any individual action. Not legal advice.

Before you list

Selling anything that might resemble their marks?

Check your design against Novartis AG Corporation's registered marks — and 13M+ others — before you list.

Check your design free

Free trial · no card · 3 checks that never expire

Federal court filings

0
Schedule-A cases
naming online sellers as defendants
5
Federal trademark cases
nature-of-suit 840
0
Federal copyright cases
nature-of-suit 820

At the Trademark Trial and Appeal Board (TTAB)

136
Oppositions
under 15 U.S.C. §1063
7
Cancellation petitions
under 15 U.S.C. §1064
60
Prevailed
on the merits, by default, or by abandonment
31
Did not prevail
adverse ruling on the merits
51
Settled / withdrawn
ended without a Board ruling on the merits

Prevailed in 66% of proceedings the Board actually decided on the merits (settled and withdrawn proceedings excluded from this calculation).

Designs Novartis AG Corporation has opposed

Real trademark applications Novartis AG Corporation challenged at the USPTO — the kind of design that draws an opposition. If your artwork looks like one of these, expect pushback. Each links to its USPTO docket.

Source: USPTO Trademark Trial and Appeal Board records. “Prevailed” means Novartis AG Corporation got the outcome it sought; settled/withdrawn cases ended without a Board ruling on the merits. Images from public USPTO records.

Marks Novartis AG Corporation has asserted in proceedings

XOLAIR
XOLAIR
asserted in 4 proceedings
MS DIALOGUES
MS DIALOGUES
asserted in 2 proceedings
ZIMBUS
ZIMBUS
asserted in 1 proceedings
NODOZ
NODOZ
asserted in 1 proceedings
MarkSerialProceedings
NOVARTIStext7513140913
NOVARTIStext783656579
ILARIStext790187977
FEMARAtext750417016
AREDIAtext740099425
ILARIStext777083335
RESTORtext780059415
MAALOXtext716054944
THERAFLUtext736371474
XOLAIR780735894
NUTRAMENT THE ENERGY AND FITNESS DRINKtext746743613
DIOVANtext750008133
THERAFLU THIN STRIPStext786915053
THERAFLU VAPOR STICKtext780383403
IQ RESTORtext857809383
NOVARTIStext860631363
ESTRADERMtext734319553
NEORALtext744480322
NOVARTIStext792099272
MS DIALOGUES861316632
CERTICANtext790241692
DERAMAXXtext780333342
ALPHA-KERItext720665432
THINK WHAT'S POSSIBLEtext786576112
VOLTARENtext724226882
VIVELLE DOTtext756382362
XOLAIRtext782966122
XOLAIRtext782697882
XOLAIRtext781099112
VISKENtext723615152
FYTAREXtext780870932
ELIDELtext751047872
LIVATEtext771090932
KYNVYTAtext791862752
KERI SILKY SMOOTHtext742082272
MS DIALOGUEStext861316612
PAIVUAtext793047212
FRESHLOOK DIMENSIONStext782031032
ZAMDRAYtext780828932
VIVELLEtext745739642
FYNEFTAtext781430431
VELIANAtext773432871
BANZELtext773346271
SEEBARItext855018261
ZIMBUS790062531
PAZEOtext857663411
NVRtext791395871
NODOZ721940271
MYFORTICtext780101341
OMNITROPEtext789068381
IGEMIEtext792528121
FRESHLOOKtext782251611
FRESHLOOK COLOR BLENDStext753596781
FRESHLOOK COLORStext782252451
FRESHLOOK COLOR STUDIOtext772827251
TRIGUARD FLEXIBAGtext781800511
MIGROBENtext780870891
TRIAMINICtext782399751
TRIAMINIC THIN STRIPStext782736631
TRIAMINIC CLINICtext782923511

From public USPTO records. A mark is listed when it appears as a senior asserted mark in TTAB or federal-court proceedings on file. Serial links open the USPTO TSDR record.

Selling a design that may resemble Novartis AG Corporation’s registered marks?

Run a visual similarity check against Novartis AG Corporation’s registered marks — and 13M+ other USPTO trademark images — before you list. Takes about 10 seconds.

Run a free visual check

FAQ

Data sources: publicly published USPTO Trademark Trial and Appeal Board proceedings (1951–2026, with possible gaps before electronic filing) and U.S. federal court dockets (PACER/CourtListener, nature-of-suit codes 840 and 820). Figures reflect filings on record and do not characterize the merits, validity, or legitimacy of any individual action by Novartis AG Corporation. Trademark holders have legal rights — and in some doctrines, an obligation — to enforce registered marks. This page does not provide legal advice; consult licensed counsel for case-specific questions. See the full leaderboard.